A concise synthesis of (3S,4S,5R)-1-(α-d-galactopyranosyl)-3- tetracosanoylamino-4,5-decanediol, a C-glycoside analogue of immunomodulating α-galactosylceramide OCH

Tetrahedron Letters

Volumn 46, Issue 30, 2005, Pages 5043-5047

  Toba, Tetsuya ^a   Murata, Kenji ^a   Yamamura, Takashi ^b   Miyake, Sachiko ^b   Annoura, Hirokazu ^a  

^a DAIICHI SANKYO CO   (Japan)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

C glycoside; CD1d; Ceramide; NKT cell ligand; OCH

Indexed keywords

1 (ALPHA DEXTRO GALACTOPYRANOSYL) 3 TETRACOSANOYLAMINO 4,5 DECANEDIOL; ALDEHYDE DERIVATIVE; ALPHA GALACTOSYLCERAMIDE; ANTIMALARIAL AGENT; ARABINOSE; CARBOHYDRATE DERIVATIVE; GALACTOSE; GLYCOSIDE; PHYTOSPHINGOSINE; UNCLASSIFIED DRUG;

ADDITION REACTION; ARTICLE; CHEMICAL PROCEDURES; CHEMICAL REACTION; DRUG SYNTHESIS;

EID: 20544439073     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2005.05.069     Document Type: Article

References (36)

1. For reviews: S.A. Porcelli, and R.L. Modlin Annu. Rev. Immunol. 17 1999 297 329
2. S. Hong, D.C. Scherer, N. Singh, S.K. Mendiratta, I. Serizawa, Y. Koezuka, and L. Van Kaer Immunol. Rev. 169 1999 31 44
3. S. Sidobre, and M. Kronenberg J. Immunol. Methods 268 2002 107 121
4. M.T. Wilson, and L. Van Kaer Curr. Pharm. Des. 9 2003 201 220
5. T. Cox Phil. Trans. R. Soc. Lond. B 358 2003 967 973
6. M. Brigl, and M.B. Brenner Annu. Rev. Immunol. 22 2004 817 890
7. M. Morita, K. Motoki, K. Akimoto, T. Natori, T. Sakai, E. Sawa, K. Yamaji, Y. Koezuka, E. Kobayashi, and H. Fukushima J. Med. Chem. 38 1995 2176 2187
8. M. Morita, E. Sawa, K. Yamaji, T. Sakai, T. Natori, Y. Koezuka, H. Fukushima, and K. Akimoto Biosci. Biotechnol. Biochem. 60 1996 288 292
9. H. Takikawa, S. Muto, and K. Mori Tetrahedron 54 1998 3141 3150
10. A. Graziani, P. Passacantilli, G. Piancatelli, and S. Tani Tetrahedron: Asymmetry 11 2000 3921 3937
11. K. Miyamoto, S. Miyake, and T. Yamamura Nature 413 2001 531 534
12. Yamamura, T.; Miyake, S. PCT Int. Appl. WO 2003/016326, 2003.
13. Chem. Abstr. 138 2003 205292m
14. T. Yamamura, K. Miyamoto, Z. Illes, E. Pal, M. Araki, and S. Miyake Curr. Top. Med. Chem. 4 2004 561 567
15. S. Oki, A. Chiba, T. Yamamura, and S. Miyake J. Clin. Invest. 113 2004 1631 1640
16. A. Chiba, S. Oki, K. Miyamoto, H. Hashimoto, T. Yamamura, and S. Miyake Arthritis Rheum. 50 2004 305 313
17. K. Murata, T. Toba, K. Nakanishi, B. Takahashi, T. Yamamura, S. Miyake, and H. Annoura J. Org. Chem. 70 2005 2398 2401
18. J. Schmieg, G. Yang, R.W. Frank, and M. Tsuji J. Exp. Med. 198 2003 1631 1641
19. G. Yang, J. Schmieg, M. Tsuji, and R.W. Frank Angew. Chem., Int. Ed. 43 2004 3818 3822 This route consists of over 20 steps for the synthesis of 2a upon counting on all the substep sequence
20. Tomiyama, H.; Yanagisawa, T.; Nimura, M.; Noda, A.; Tomiyama, T. JP 2001/354666, 2002.
21. Chem. Abstr. 136 2002 37901x This route was unreproducible and the final product was unable to be isolated due to considerable amounts of inseparable contaminants
22. 6b and more practical for 2a which completes in only 11 steps, however, it requires the commercially available phytosphingosine and is not expandable enough for analogue syntheses including 2b. Preparing commercially unavailable phytosphingosine derivatives for this route must require several additional steps, which makes this route less attractive for SAR purposes
23. For examples of the syntheses of phytosphingosine derivatives, see: C.-C. Lin, G.-T. Fan, and J.-M. Fang Tetrahedron Lett. 44 2003 5281 5283
24. H.-Y. Chiu, D.-L.M. Tzou, L.N. Patkar, and C.-C. Lin J. Org. Chem. 68 2003 5788 5791 and references cited therein
25. A. Dondoni, G. Mariotti, and A. Marra J. Org. Chem. 67 2002 4475 4486
26. A.A. Sabino, and R.A. Pilli Tetrahedron Lett. 43 2002 2819 2821
27. In this reaction, the starting α-ethynyl-galactopyranose 5 was usually recovered unchanged in over 15% yield.
28. I. Ohtani, T. Kusumi, Y. Kashman, and H. Kakisawa J. Am. Chem. Soc. 113 1991 4092 4096
29. 3): δ 7.6-7.57 (m, 2H), 7.5-7.2 (m, 23H), 5.66 (dd, 1H, J = 8.9 Hz, 1.8 Hz), 4.90 (d, 1H, J = 11.4 Hz), 4.80 (dd, 1H, J = 6.0 Hz, 1.8 Hz), 4.77 (d, 1H, J = 11.7 Hz), 4.69 (d, 1H, J = 11.7 Hz), 4.68 (d, 1H, J = 11.7 Hz), 4.61 (d, 1H, J = 11.7 Hz), 4.55 (d, 1H, J = 11.4 Hz), 4.45 (d, 1H, J = 11.9 Hz), 4.37 (d, 1H, J = 11.9 Hz), 4.26 (dd, 1H, J = 8.9 Hz, 5.7 Hz), 4.11 (ddd, 1H, J = 13.6 Hz, 5.7 Hz, 3.2 Hz), 4.06 (dd, 1H, J = 9.8 Hz, 5.9 Hz), 3.96 (t, 3H, J = 6.4 Hz), 3.93-3.91 (m, 1H), 3.72 (dd, 1H, J = 9.8 Hz, 2.8 Hz), 3.57 (s, 3H), 3.5-3.4 (m, 2H), 1.75-1.55 (m, 2H), 1.55-1.5 (m, 1H), 1.40 (s, 3H), 1.32 (s, 3H), 1.3-1.1 (m, 5H), 0.81 (t, 3H, J = 6.8 Hz).
30. R.L. Soucy, D. Kozhinov, and V. Behar J. Org. Chem. 67 2002 1947 1952
31. K. Shimada, Y. Kaburagi, and T. Fukuyama J. Am. Chem. Soc. 125 2003 4048 4049
32. Y. Tamura, H. Annoura, M. Fuji, T. Yoshida, R. Takeuchi, and H. Fujioka Chem. Pharm. Bull. 35 1987 4736 4746
33. M.T. Reez Angew. Chem., Int. Ed. Engl. 23 1984 556 569
34. The total chemical yield of 10a,b was decreased to 39% with a similar diastereomeric ratio when the magnesium acetylide of 5 was used in this reaction. The zinc acetylide derived from 5 produced only a trace of 10a,b.
35. 8, 702.5884, found 702.5853.
36. The effect of 2b in several animal models of autoimmune disease is currently under investigation and will be reported elsewhere.